No Data
No Data
BofA Securities Upgrades United Therapeutics(UTHR.US) to Hold Rating, Cuts Target Price to $314
J.P. Morgan Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $355
Express News | JP Morgan Maintains Overweight on United Therapeutics, Lowers Price Target to $355
Express News | United Therapeutics Corp : BofA Global Research Raises to Neutral From Underperform
Express News | B of A Securities Upgrades United Therapeutics to Neutral, Maintains Price Target to $314
United Therapeutics Analyst Ratings